FIELD: chemistry.
SUBSTANCE: invention relates to substituted pyrrolidine-2-carboxamides of formula I or their pharmaceutically acceptable salts, where values X, Y, R1, R2, R3, R3, R4, R5, R6 and R7 are given in item 1 of the formula. Compounds can be used in pharmaceutical composition, inhibiting interaction of MDM2-p53.
EFFECT: compounds can be used as anti-cancer medications.
46 cl, 4 dwg, 347 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED PYRROLIDIN-2-CARBOXAMIDE | 2011 |
|
RU2564022C2 |
COMBINED THERAPY BASED ON CD20 ANTIBODY COMBINED WITH BCL-2 INHIBITOR AND MDM2 INHIBITOR | 2016 |
|
RU2727196C2 |
PYRROLIDINE DERIVATIVES | 2010 |
|
RU2562605C2 |
N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR TREATING CANCER | 2005 |
|
RU2427572C2 |
PYRAZOLES | 2006 |
|
RU2381217C2 |
PYRROLIDINE DERIVATIVES AS NK-3 ANTAGONISTS | 2012 |
|
RU2598604C2 |
PYRROLIDINE DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS | 2010 |
|
RU2561271C2 |
SPIROINDOLINONE PYRROLIDINES, USEFUL WHEN TREATING MALIGNANT GROWTHS | 2010 |
|
RU2571100C2 |
LIGAND CONJUGATE WITH CYTOTOXIC DRUG PREPARATION, METHOD AND APPLICATION THEREOF | 2016 |
|
RU2708461C2 |
NOVEL CYCLOPENTANE DERIVATIVES | 2010 |
|
RU2572555C2 |
Authors
Dates
2014-02-10—Published
2009-09-08—Filed